• Discover Astex
    • Our Mission & Values
    • Our Leadership Team
    • Research Fellows
    • Our History
    • Corporate Social Responsibility
    • Environmental Sustainability
  • R&D
    • Clinical Pipeline
    • Pyramid™ Discovery Platform
    • Oncology and CNS Discovery
    • Sustaining Innovation Postdocs
  • Partnering
  • Our People & Culture
    • Career Opportunities
  • Media
    • Press Releases
    • Conferences & Meetings
    • Presentations & Publications
    • Interactive Scientific Resources
      • Interactive Software
    • Astex in the News
  • Contact
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
You are here: Home1 / 20122 / Astex Pharmaceuticals to Announce 2012 First Quarter Financial Results...

Astex Pharmaceuticals to Announce 2012 First Quarter Financial Results on April 30, 2012

24 April 2012/in 2012, News

Astex Pharmaceuticals to Announce 2012 First Quarter Financial Results on April 30, 2012

https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg 0 0 webadmin https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg webadmin2012-04-24 09:58:572026-09-21 14:05:53Astex Pharmaceuticals to Announce 2012 First Quarter Financial Results on April 30, 2012

© Astex Pharmaceuticals
All rights reserved

astex

Useful links

  • Home
  • Sitemap
  • Privacy Policy
  • Terms of Use
  • Legal
  • LinkedIn

Member of the Otsuka Group

A selection of photos on this website
is courtesy of Valerio Berdini

Link to: Astex Pharmaceuticals to Present AT26893, a Novel Targeted Approach to the Treatment of HCV at EASL Link to: Astex Pharmaceuticals to Present AT26893, a Novel Targeted Approach to the Treatment of HCV at EASL Astex Pharmaceuticals to Present AT26893, a Novel Targeted Approach to the Treatment... Link to: 2012 AACR: Scale up & development of a process for a low volume subcutaneous formulation of SGI-110 Link to: 2012 AACR: Scale up & development of a process for a low volume subcutaneous formulation of SGI-110 2012 AACR: Scale up & development of a process for a low volume subcutaneous...
Scroll to top Scroll to top Scroll to top